PULMONX CORPORATION Operating Cash Flow
PULMONX CORPORATION (LUNG) reported Operating Cash Flow of -$15.31 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-04
- PULMONX CORPORATION net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$5.21M.
- PULMONX CORPORATION net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$10.10M.
- PULMONX CORPORATION net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$7.08M.
- PULMONX CORPORATION net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$8.16M.
- PULMONX CORPORATION net cash provided by (used in) operating activities for fiscal 2025 was -$32.38M.
- PULMONX CORPORATION net cash provided by (used in) operating activities for fiscal 2024 was -$31.54M.
- PULMONX CORPORATION net cash provided by (used in) operating activities for fiscal 2023 was -$37.61M.
- PULMONX CORPORATION net cash provided by (used in) operating activities for fiscal 2022 was -$45.08M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$5.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$15.31M 10-Q · filed 2026-08-04 | -$22.39M derived: sum of 3 quarters · filed 2026-08-04 | -$30.56M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | -$10.10M 10-Q · filed 2026-05-04 | -$17.18M derived: sum of 2 quarters · filed 2026-05-04 | -$25.34M derived: sum of 3 quarters · filed 2026-05-04 | -$29.25M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | -$7.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$15.25M derived: sum of 2 quarters · filed 2026-03-10 | -$19.15M derived: sum of 3 quarters · filed 2026-08-04 | -$32.38M 10-K · filed 2026-03-10 |
| 2025-09-30 | -$8.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$12.07M derived: sum of 2 quarters · filed 2026-08-04 | -$25.29M 10-Q · filed 2025-11-12 | -$32.02M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | -$3.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$17.13M 10-Q · filed 2026-08-04 | -$23.86M derived: sum of 3 quarters · filed 2026-08-04 | -$31.10M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | -$13.22M 10-Q · filed 2026-05-04 | -$19.95M derived: sum of 2 quarters · filed 2026-05-04 | -$27.19M derived: sum of 3 quarters · filed 2026-05-04 | -$32.96M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | -$6.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$13.97M derived: sum of 2 quarters · filed 2026-03-10 | -$19.74M derived: sum of 3 quarters · filed 2026-03-10 | -$31.54M 10-K · filed 2026-03-10 |
| 2024-09-30 | -$7.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$13.01M derived: sum of 2 quarters · filed 2025-11-12 | -$24.81M 10-Q · filed 2025-11-12 | -$33.26M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$5.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | -$17.57M 10-Q · filed 2025-08-01 | -$26.01M derived: sum of 3 quarters · filed 2025-08-01 | -$34.64M derived: sum of 4 quarters · filed 2025-08-01 |
| 2024-03-31 | -$11.79M 10-Q · filed 2025-05-02 | -$20.24M derived: sum of 2 quarters · filed 2025-05-02 | -$28.87M derived: sum of 3 quarters · filed 2025-05-02 | -$36.76M derived: sum of 4 quarters · filed 2025-05-02 |
| 2023-12-31 | -$8.45M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$17.07M derived: sum of 2 quarters · filed 2025-02-25 | -$24.97M derived: sum of 3 quarters · filed 2025-02-25 | -$37.61M 10-K · filed 2025-02-25 |
| 2023-09-30 | -$8.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | -$16.52M derived: sum of 2 quarters · filed 2024-11-01 | -$29.16M 10-Q · filed 2024-11-01 | -$38.97M derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | -$7.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | -$20.54M 10-Q · filed 2024-08-02 | -$30.34M derived: sum of 3 quarters · filed 2024-08-02 | -$41.03M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | -$12.64M 10-Q · filed 2024-05-03 | -$22.45M derived: sum of 2 quarters · filed 2024-05-03 | -$33.14M derived: sum of 3 quarters · filed 2024-05-03 | -$42.70M derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | -$9.81M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$20.49M derived: sum of 2 quarters · filed 2024-02-27 | -$30.06M derived: sum of 3 quarters · filed 2024-02-27 | -$45.08M 10-K · filed 2024-02-27 |
| 2022-09-30 | -$10.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$20.25M derived: sum of 2 quarters · filed 2023-11-03 | -$35.28M 10-Q · filed 2023-11-03 | -$45.99M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | -$9.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$24.59M 10-Q · filed 2023-08-04 | -$35.30M derived: sum of 3 quarters · filed 2023-08-04 | -$43.62M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | -$15.03M 10-Q · filed 2023-05-08 | -$25.74M derived: sum of 2 quarters · filed 2023-05-08 | -$34.05M derived: sum of 3 quarters · filed 2023-05-08 | -$46.74M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | -$10.71M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$19.03M derived: sum of 2 quarters · filed 2023-03-01 | -$31.72M derived: sum of 3 quarters · filed 2023-03-01 | -$41.39M 10-K · filed 2023-03-01 |
| 2021-09-30 | -$8.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$21.00M derived: sum of 2 quarters · filed 2022-11-08 | -$30.68M 10-Q · filed 2022-11-08 | -$37.94M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$12.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$22.36M 10-Q · filed 2022-08-08 | -$29.62M derived: sum of 3 quarters · filed 2022-08-08 | -$35.45M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | -$9.67M 10-Q · filed 2022-05-09 | -$16.93M derived: sum of 2 quarters · filed 2022-05-09 | -$22.76M derived: sum of 3 quarters · filed 2022-05-09 | -$30.46M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | -$7.26M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$13.09M derived: sum of 2 quarters · filed 2022-03-01 | -$20.78M derived: sum of 3 quarters · filed 2022-03-01 | -$30.63M 10-K · filed 2022-03-01 |
| 2020-09-30 | -$5.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$13.52M derived: sum of 2 quarters · filed 2021-11-09 | -$23.37M 10-Q · filed 2021-11-09 | -$26.84M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$7.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$17.54M 10-Q · filed 2021-08-10 | -$21.01M derived: sum of 3 quarters · filed 2021-08-10 | |
| 2020-03-31 | -$9.85M 10-Q · filed 2021-05-12 | -$13.32M derived: sum of 2 quarters · filed 2021-05-12 | ||
| 2019-12-31 | -$3.47M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | -$20.77M 10-K · filed 2021-03-15 | ||
| 2019-09-30 | -$17.29M 10-Q · filed 2020-11-13 | |||
| 2018-12-31 | -$18.39M 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |